Cargando…

Drivers of year-to-year variation in exacerbation frequency of COPD: analysis of the AERIS cohort

The association between exacerbation aetiology and exacerbation frequency is poorly understood. We analysed 2-year follow-up data from a prospective observational study of patients with chronic obstructive pulmonary disease (COPD) (www.clinicaltrials.gov identifier number NCT01360398) to evaluate ye...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wilkinson, Tom M.A., Aris, Emmanuel, Bourne, Simon C., Clarke, Stuart C., Peeters, Mathieu, Pascal, Thierry G., Taddei, Laura, Tuck, Andrew C., Kim, Viktoriya L., Ostridge, Kristoffer K., Staples, Karl J., Williams, Nicholas P., Williams, Anthony P., Wootton, Stephen A., Devaster, Jeanne-Marie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6387989/ https://www.ncbi.nlm.nih.gov/pubmed/30815467 http://dx.doi.org/10.1183/23120541.00248-2018

Ejemplares similares

Acute Exacerbation and Respiratory InfectionS in COPD (AERIS): protocol for a prospective, observational cohort study
por: Bourne, Simon, et al.
Publicado: (2014)

Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations
por: Mayhew, David, et al.
Publicado: (2018)

A prospective, observational cohort study of the seasonal dynamics of airway pathogens in the aetiology of exacerbations in COPD
por: Wilkinson, Tom M A, et al.
Publicado: (2017)

Impact of radiologically stratified exacerbations: insights into pneumonia aetiology in COPD
por: Williams, Nicholas P., et al.
Publicado: (2018)

Relationship of CT-quantified emphysema, small airways disease and bronchial wall dimensions with physiological, inflammatory and infective measures in COPD
por: Ostridge, Kristoffer, et al.
Publicado: (2018)

Distinct emphysema subtypes defined by quantitative CT analysis are associated with specific pulmonary matrix metalloproteinases
por: Ostridge, Kristoffer, et al.
Publicado: (2016)

Relationships between Mucosal Antibodies, Non-Typeable Haemophilus influenzae (NTHi) Infection and Airway Inflammation in COPD
por: Staples, Karl J., et al.
Publicado: (2016)

Correction: Relationships between Mucosal Antibodies, Non-Typeable Haemophilus influenzae (NTHi) Infection and Airway Inflammation in COPD
por: Staples, Karl J., et al.
Publicado: (2017)

Severe Emphysema Treated by Endoscopic Bronchial Volume Reduction with Lung Sealant (AeriSeal)
por: Falkenstern-Ge, R. F., et al.
Publicado: (2013)

Do the benefits continue? Long term impacts of the Anatomy Education Research Institute (AERI) 2017
por: Husmann, Polly R., et al.
Publicado: (2022)

“Drivers of year-to-year variation in exacerbation frequency of COPD: analysis of the AERIS cohort” Tom M.A. Wilkinson, Emmanuel Aris, Simon C. Bourne, Stuart C. Clarke, Mathieu Peeters, Thierry G. Pascal, Laura Taddei, Andrew C. Tuck, Viktoriya L. Kim, Kristoffer K. Ostridge, Karl J. Staples, Nicholas P. Williams, Anthony P. Williams, Stephen A. Wootton and Jeanne-Marie Devaster, on behalf of the AERIS Study Group. ERJ Open Res 2019; 5: 00248-2018.
Publicado: (2019)

Human CD49a(+) Lung Natural Killer Cell Cytotoxicity in Response to Influenza A Virus
por: Cooper, Grace E., et al.
Publicado: (2018)

Pulmonary EV miRNA profiles identify disease and distinct inflammatory endotypes in COPD
por: Burke, Hannah, et al.
Publicado: (2022)

Account of the Employment of Very Large Quantities of the Ærugo Æris, Exhibited Internally to Horses, with a View to the Cure of Glanders
por: Lawson, Robert
Publicado: (1800)

One-year mortality after severe COPD exacerbation in Bulgaria
por: Mekov, Evgeni, et al.
Publicado: (2016)

Seasonal influenza vaccination in patients with COPD: a systematic literature review
por: Bekkat-Berkani, Rafik, et al.
Publicado: (2017)

Immunogenicity and safety of quadrivalent versus trivalent inactivated influenza vaccine: a randomized, controlled trial in adults
por: Beran, Jiří, et al.
Publicado: (2013)

Predictors of one-year mortality after hospitalization for an exacerbation of COPD
por: Esteban, Cristóbal, et al.
Publicado: (2018)

Clinical Features and C-Reactive Protein as Predictors of Bacterial Exacerbations of COPD
por: Francis, Nick A, et al.
Publicado: (2020)

Predictors of exacerbations of asthma and COPD during one year in primary care
por: Al-ani, Salwan, et al.
Publicado: (2013)

The influence of anemia on one-year exacerbation rate of patients with COPD-PH
por: Xiong, Wei, et al.
Publicado: (2018)

Dysregulation of COVID-19 related gene expression in the COPD lung
por: Watson, Alastair, et al.
Publicado: (2021)

Strategies for improving outcomes of COPD exacerbations
por: Wilkinson, Tom, et al.
Publicado: (2006)

Acquired immune responses to the seasonal trivalent influenza vaccination in COPD
por: Staples, K. J., et al.
Publicado: (2019)

Prognostic role of D-dimer for in-hospital and 1-year mortality in exacerbations of COPD
por: Hu, Guoping, et al.
Publicado: (2016)

Should the number of acute exacerbations in the previous year be used to guide treatments in COPD?
por: Sadatsafavi, Mohsen, et al.
Publicado: (2021)

COPD Exacerbation History and Impact on Future Exacerbations – 8-Year Retrospective Observational Database Cohort Study from Germany
por: Vogelmeier, Claus F, et al.
Publicado: (2021)

Antibiotics against Pseudomonas aeruginosa for COPD exacerbation in ICU: a 10-year retrospective study
por: Planquette, Benjamin, et al.
Publicado: (2015)

Risk of Nonlower Respiratory Serious Adverse Events Following COPD Exacerbations in the 4-year UPLIFT(®) Trial
por: Halpin, David M. G., et al.
Publicado: (2011)

A one-year prospective study of infectious etiology in patients hospitalized with acute exacerbations of COPD and concomitant pneumonia
por: Ko, Fanny W.S., et al.
Publicado: (2008)

Interleukin-6 is a Strong Predictor of the Frequency of COPD Exacerbation Within 1 Year
por: Huang, Hui, et al.
Publicado: (2021)

Spatiotemporal patterns and environmental drivers of human echinococcoses over a twenty-year period in Ningxia Hui Autonomous Region, China
por: Cadavid Restrepo, Angela M., et al.
Publicado: (2018)

Predicting and preventing hospital readmission for exacerbations of COPD
por: Kong, Chia Wei, et al.
Publicado: (2020)

Real-time PCR has advantages over culture-based methods in identifying major airway bacterial pathogens in chronic obstructive pulmonary disease: Results from three clinical studies in Europe and North America
por: Schoonbroodt, Sonia, et al.
Publicado: (2023)

A COPD-like model of viral exacerbation: synergistic effects with smoke and poly I:C
por: Schlerman, F, et al.
Publicado: (2013)

Twenty years of telemedicine in chronic disease management – an evidence synthesis
por: Wootton, Richard
Publicado: (2012)

Factors associated with coronary heart disease in COPD patients and controls
por: Svendsen, Christina D., et al.
Publicado: (2022)

The long-term clinical impact of COPD exacerbations: a 3-year observational study (SHERLOCK)
por: Haughney, John, et al.
Publicado: (2022)

Early diagnostic BioMARKers in exacerbations of chronic obstructive pulmonary disease: protocol of the exploratory, prospective, longitudinal, single-centre, observational MARKED study
por: Waeijen-Smit, Kiki, et al.
Publicado: (2023)

Airway pathogens detected in stable and exacerbated COPD in patients in Asia-Pacific
por: Taddei, Laura, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_anho7eom36d21jqdkubd1p9p0t